Vanberra Signal

Lutroo Imaging

Curated by Signal

Developer of molecular diagnostic technology for chronic pain

Overview

Developer of molecular diagnostic technology for chronic pain. Their technology allows for pain visualization and aims to set people free from the captivity of chronic pain. It offers Radiocaine, a PET radiotracer that enables pain visualization with the help of an AI-based imaging analysis platform.

Key facts

Founded
2021

Business model

Contact

More on Vanberra Signal

Members only

Competitors & similar companies

More Life Sciences Technology companies
  • Developer of AI-based robotic radiosurgery planning and delivery systems

    Life Sciences TechnologySunnyvale, United States
  • Head worn device to prevent and treat Alzheimer's Disease with electromagnetic waves

    Life Sciences TechnologyPhoenix, United States
  • AI-based disease diagnosis and genomic analysis tool for providers

    Life Sciences TechnologyOakland, United States

About Lutroo Imaging

What does Lutroo Imaging do?

Developer of molecular diagnostic technology for chronic pain.

Where is Lutroo Imaging headquartered?

Lutroo Imaging is headquartered in Kalispell, United States.

When was Lutroo Imaging founded?

Lutroo Imaging was founded in 2021.

Which sector is Lutroo Imaging in?

Lutroo Imaging operates in Life Sciences Technology.

Who are Lutroo Imaging's competitors?

Companies similar to Lutroo Imaging include Accuray, NeuroEM, and Fabric Genomics.